Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection model

OBJECTIVES: Pharmacodynamic profiling of oral ciprofloxacin dosing for urinary tract infections caused by ceftriaxone-resistant Escherichia coli isolates with ciprofloxacin MIC ≥ 0.25 mg/L. BACKGROUND: Urine-specific breakpoints for ciprofloxacin do not exist. However, high urinary concentrations ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbott, Iain J, van Gorp, Elke, Cottingham, Hugh, Macesic, Nenad, Wallis, Steven C, Roberts, Jason A, Meletiadis, Joseph, Peleg, Anton Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890216/
https://www.ncbi.nlm.nih.gov/pubmed/36473954
http://dx.doi.org/10.1093/jac/dkac402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890216/
https://www.ncbi.nlm.nih.gov/pubmed/36473954
http://dx.doi.org/10.1093/jac/dkac402

Ejemplares similares